Summary & Overview
HCPCS G9450: History of Injection Drug Use
HCPCS Level II code G9450 documents a documented history of injection drug use in a patient’s medical record. Nationally, clear capture of substance use history supports clinical decision-making, care coordination, risk stratification, and public health surveillance. Accurate use of G9450 can affect quality reporting and care pathways for patients with prior injection drug exposure.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, the typical settings where it is reported, and what to expect in payer coverage patterns. The publication outlines common administrative considerations, coding relationships, and the implications for documentation and reporting workflows.
This resource summarizes benchmarks and common billing practices for G9450, highlights relevant policy updates affecting HCPCS Level II social and behavioral health categories, and provides clinical context to help billing teams and compliance staff align documentation with the code’s intended use.
Billing Code Overview
HCPCS Level II code G9450 indicates a history of injection drug use. This code is used to document a patient record element reflecting past injection drug use as part of clinical and administrative documentation.
-
Service type: Behavioral health / substance use history assessment
-
Typical site of service: Outpatient clinic, behavioral health clinic, primary care office, or other ambulatory settings
Clinical & Coding Specifications
Clinical Context
A 34-year-old person presents to a community health clinic for an intake visit focused on substance use history and related risk assessment. The patient discloses previous injection drug use during episodic opioid misuse several years prior and requests screening for bloodborne infections, counseling about wound care, and referral to harm reduction services. The clinical workflow includes intake registration, review of past medical and social history, targeted substance-use history documentation (including frequency, substances injected, sharing of equipment, and date of last injection), focused physical exam of injection sites, ordering of laboratory testing (HIV antigen/antibody, Hepatitis B surface antigen and core antibody, Hepatitis C antibody and RNA), provision of wound care or immunizations as indicated (tetanus, Hepatitis B vaccine series if susceptible), counseling and referral to syringe services, and documentation of the history of injection drug use using billing code G9450 on the claim. Typical encounter sites are outpatient clinics, community health centers, syringe service programs, and emergency departments performing intake and risk assessment. The typical patient scenario includes linkage to specialty care (infectious disease or addiction medicine) when testing is positive or when the patient requests treatment for substance use disorder.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased Procedural Services |